Art & Culture
Foreign Affairs
Parliament of India
United Nations
Photo Gallery
Advertise with Us
Contact Us


India sees new high in daily Covid tally in 3 months with 8,822 new cases

NEW DELHI, June 15: India on Wednesday saw a new high in around three months in the daily Covid tally with 8,822 new cases in the last 24 hours, taking the overall count to 4,32,45,517. According to the health ministry data, a total of 15 deaths have been reported since Tuesday - with the total fatalities due to the virus at 5,24,792.

The active cases currently stand at 53,637. The active cases account for 0.12 percent of the total caseload. The health ministry data mentioned that the recovery rate in the country is currently at 98.67 percent as 5,718 people recovered in the last 24 hours.

According to the data, the daily positivity rate is at 2 percent, while the weekly positivity rate is at 2.35 percent.

A total of 85.58 crore samples have been tested so far for coronavirus, with 4,40,278 tests being conducted in the last 24 hours.

India's vaccine coverage has reached 195.5 crore doses. Over 3.53 crore first doses and over 1.99 crore second doses have been administered for the age group of 12 to 14. Over 5.99 crore first doses and more than 4.72 crore second doses have been given to the 15 to 18 age group. Meanwhile, over 3.61 crore precaution doses (booster shots) have been given to people above 60 years of age, healthcare workers, and frontline workers.

Meanwhile, Delhi is recording a surge in the daily cases and the national capital's daily tally breached the 1,000-mark again. The national capital recorded 1,118 fresh infections on Tuesday. Maharashtra has also been witnessing a huge spike over the last few days.

India records 7,240 new COVID-19 cases, 8 deaths

NEW DELHI, June 9: The single-day rise in new coronavirus infections in the country was recorded over 7,000 after 99 days, registering around 39 per cent jump in daily cases, while the daily positivity rate crossed 2 per cent after 111 days, the Union Health Ministry said on Thursday.

A total of 7,240 infections were recorded in a span of 24 hours taking India's total tally of COVID-19 cases to 4,31,97,522, while the death toll has climbed to 5,24,723 with eight fresh fatalities, data updated at 8 am by the ministry stated.

The active cases have increased to 32,498, comprising 0.08 per cent of the total infections, while the national COVID-19 recovery rate was recorded at 98.71 per cent, the health ministry said. A total of 7,554 new Covid cases were reported on March 1.

An increase of 3,641 cases has been recorded in the active COVID-19 case count in a span of 24 hours. The daily positivity rate was recorded at 2.13 per cent while the weekly positivity rate was also recorded at 1.31 per cent, according to the data.

The number of people who have recuperated from the disease surged to 4,26,40,301 , while the case fatality rate was recorded at 1.21 per cent. The cumulative doses administered in the country so far under the nationwide COVID-19 vaccination drive has exceeded 194.59 crore.

India's COVID-19 tally had crossed the 20-lakh mark on August 7, 2020, 30 lakh on August 23, 40 lakh on September 5 and 50 lakh on September 16. It went past 60 lakh on September 28, 70 lakh on October 11, crossed 80 lakh on October 29, 90 lakh on November 20 and surpassed the one-crore mark on December 19, 2020.

India crossed the grim milestone of two crore cases on May 4 and three crore on June 23, 2021. The eight new fatalities include one each from Delhi and Chhattisgarh and six deaths from Kerala.

First Time In History Cancer Vanishes For Every Patient In Drug Trial

NEW YORK, June 7: A small group of people with rectal cancer just experienced something of a miracle as their cancer simply vanished after an experimental treatment. According to New York Times, in a very small clinical trial, 18 patients took a drug called Dostarlimab for around six months, and in the end, every one of them saw their tumours disappear.

Dostarlimab is a drug with laboratory-produced molecules that act as substitute antibodies in the human body. All 18 rectal cancer patients were given the same drug and as a result of the treatment, cancer was completely obliterated in every patient - undetectable by physical exam; endoscopy; positron emission tomography or PET scans or MRI scans.

Dr Luis A. Diaz J. of New York's Memorial Sloan Kettering Cancer Center said this was “the first time this has happened in the history of cancer”.

As per New York Times, the patients involved in the clinical trial faced gruelling previous treatments to obliterate their cancer, such as chemotherapy, radiation and invasive surgery that could result in bowel, urinary and even sexual dysfunction. The 18 patients went into the trial expecting to have to go through these as the next step. However, to their surprise, no further treatment was needed.

The findings are now making waves in the medical world. Speaking to the media outlet, Dr Alan P. Venook, who is a colorectal cancer specialist at the University of California, said that the complete remission in every single patient is “unheard-of”. He hailed the research as a world-first. He even noted that it was especially impressive as not all of the patients suffered significant complications from the trial drug.

Separately, Memorial Sloan Kettering Cancer Center and a co-author of the paper, oncologist Dr Andrea Cercek, described the moment patients found out they were cancer-free. “There were a lot of happy tears,” she told the New York Times.

For the trial, patients took Dostarlimab every three weeks for six months. They were all in similar stages of their cancer - it was locally advanced in the rectum but had not spread to other organs.

Now, the cancer researchers who reviewed the drug told the media outlet that the treatment looks promising, but a larger-scale trial is needed to see if it will work for more patients and if the cancers are truly in remission.

WHO expert lists 5 measures to stop monkeypox

GENEVA, June 6: The monkeypox virus has been reported in around 30 countries where the infection is not endemic in what is the biggest outbreak of the virus. More than 780 confirmed or suspected infections of the virus have been reported, most of which are in Europe.

As the cases rise, the World Health Organisation (WHO) has issued new guidelines and measures to prevent the virus from spreading. Dr. Maria Van Kerkhove, a WHO epidemiologist, detailed a list of key measures to stop monkeypox after studying the virus epidemiology, sources of infection, and transmission patterns.

The senior health officer suggested increasing surveillance in countries where the virus is not endemic and urged creating awareness about what monkeypox is and how it spreads, especially in countries like the US, Canada, Australia, Germany, and France. The global health body called on governments to ensure that people who are expected to be affected can get appropriate clinical care.

The second step in order to stop the spread of this virus is to stop human-to-human contraction in several non-endemic countries by using public health tools of early identification, which includes isolating cases and talking and listening to communities to find solutions.

Dr. Maria Van Kerkhove further said that the protection of frontline workers is also important because they are the ones who work at ground level and directly provide services to the public. "It is crucial to supply them with accurate information and appropriate personal protective equipment. Counter measures against this virus should be utilised properly by providing antivirals and vaccines appropriately to those who are more at risk in an equal manner," Dr. Kerkhove said.

WHO is hosting a research and development meeting next week that will cover everything from epidemiology to diagnostics, treatments, and vaccinations, since it is essential to understand what monkeypox is.

While no confirmed cases have been reported in India, a 5-year-old girl's sample was collected for monkeypox testing in Ghaziabad. Meanwhile, Genetic analysis of recent monkeypox cases suggests there are two distinct strains in the US. Many of the U.S. cases were caused by the same strain as recent cases in Europe, but a few samples show a different strain, federal health officials said.

Monkeypox belongs to the Orthopoxvirus genus in the family Poxviridae which also includes variola virus (which causes smallpox), vaccinia virus (used in the smallpox vaccine), and cowpox virus. Monkeypox typically causes fever, chills, rash, and lesions on the face or genitals. WHO estimates the disease is fatal for up to one in 10 people.



Monkeypox Cases Spread 'Tip Of The Iceberg': WHO

Omicron subvariants BA.4 and BA.5 in India: Symptoms, severity

Scientists 'reverse death', bring dead eyes back to life



Aviation | Business | Defence | Foreign Affairs | Communication | Health | India | United Nations
India-US | India-France | Entertainment | Sports | Photo Gallery | Tourism | Advertise with Us | Contact Us

Best viewed at 800 x 600 resolution with IE 4.0 or higher
© Noyanika International, 2003-2009. All rights reserved.